- Rising prevalence of premenstrual dysphoric disorder is stimulating growth in premenstrual syndrome treatment market
- Increasing demand for vitamin supplements and herbal medication assisting in expansion of overall market
- North America accounted for significant share in overall market in 2021 due to increasing number of women suffering from menstrual discomfort in the U.S. and Canada
WILMINGTON, Del., Oct. 19, 2022 /PRNewswire/ -- The last decade has witnessed a surge in working population globally across different end-use industries, which has increased level of exhaustion, among women and also led to medical conditions such as premenstrual syndrome, characterized by symptoms such as acne and mood swings, which has increased the demand for premenstrual syndrome treatment.
As per a study conducted by Transparency Market Research, the global premenstrual syndrome treatment market is expected to advance at compound annual growth rate of 3.4% during the forecast period, starting in 2022 and ending in 2031.
Launch of new premenstrual syndrome treatment medicines is helping leading market players in gaining a competitive edge over other market players and generate new revenue streams.
Get Exclusive PDF Sample Copy of Premenstrual Syndrome Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2922
Fresenius Kabi, in 2021, announced the launch of new injection in freeflex bags in the U.S. The product has proven beneficial in decreasing fever and managing pain.
In a bid to improve their revenue and expand their presence in global market, prominent premenstrual syndrome treatment market players are signing collaborative agreements with smaller market players.
Key Findings of Premenstrual Syndrome Treatment Market
- Increasing Prevalence of Premenstrual Dysphoric Disorders Boosting Growth in Premenstrual Syndrome Treatment Market: The last few years have witnessed a significant rise in women suffering from premenstrual dysphoric disorder. Key reasons behind the increased prevalence of the disease are hectic schedules and sedentary lifestyles among the working population. As a result, the need for premenstrual syndrome treatment is rising, which is triggering the growth in premenstrual syndrome treatment market
- Rising Demand for Vitamin Supplements Propelling Overall Market: Leading manufacturers in global premenstrual syndrome treatment market are focusing on herbal medicines and vitamin nutritional supplements to help patients manage premenstrual syndrome. Supplements containing micronutrients such as magnesium and calcium are witnessing high demand since products containing these ingredients have helped treat premenstrual syndrome, effectively. Key reason for the focus on vitamin supplements and herbal medication is to reduce the consumption of antidepressants and anti-inflammatory drugs, which could lead to side-effects
Ask for References -https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2922
Premenstrual Syndrome Treatment Market: Key Drivers
- Rising awareness of luteal phase therapy among patients is one of the key growth drivers of global premenstrual syndrome treatment market
- Increasing demand for oral contraceptives and ovarian suppression drugs is augmenting growth in premenstrual syndrome treatment market
Premenstrual Syndrome Treatment Market: Regional Market Insights
- Globally, North America held a substantial share in overall premenstrual syndrome treatment market, in 2021. Rising number of women suffering from menstrual discomfort in countries such as the U.S. and Canada emerged as the key growth driver of the global market in the region
- Asia Pacific is expected to witness significant growth in premenstrual syndrome treatment market during the forecast period due to growing awareness about premenstrual treatment among patients in countries such as India and China
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2922
Premenstrual Syndrome Treatment Market: Key Players
The global premenstrual syndrome treatment market comprises numerous well-established market players and as a result, the competition is intense. Entry of new players could further intensify the competition in global market, during the forecast period.
Leading premenstrual syndrome treatment market players are making huge investments in research and development activities in a bid to produce improved products that would meet consumer requirements in different age groups.
Few leading players in global premenstrual syndrome treatment market include Pfizer Inc., Bayer AG, Johnson and Johnson Services Inc., Allergan, and Teva Pharmaceutical Industries Inc.
The global premenstrual syndrome treatment market is segmented as follows:
- Drug Type
- Antidepressants
- Diuretics
- Pain Relievers
- Oral Contraceptives & Ovarian Suppression Agents
- Others
- Distribution Channel
- Retail Pharmacies
- E-commerce
- Others
- Regions Covered
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Pain Management Therapeutics Market: The global pain management therapeutics market is anticipated to reach more than US$ 98.0 Bn by the end of 2031 at a CAGR of 2.9% from 2022 to 2031.
Peptide Therapeutics Market: The global peptide therapeutics market is anticipated to reach more than US$ 91.25 Bn by 2031 at a CAGR of 8.8% from 2022 to 2031.
Collagen Peptide & Gelatin Market: The global collagen peptide and gelatin market is anticipated to reach more than US$ 7.8 Bn by the end of 2031 at a CAGR of 5.0% from 2022 to 2031.
Synthetic Biology Market: The global synthetic biology market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 at a CAGR of 21.3% from 2022 to 2031.
Electronic Health Records [EHR] Market: The global electronic health records (EHR) market is anticipated to reach more than US$ 50.3 Bn by the end of 2031 at a CAGR of 5.0% from 2022 to 2031.
Ophthalmic Drugs Market: The ophthalmic drugs market is expected to reach US$ 50.2 Bn by the end of 2031 at a CAGR of 6.83% from 2022 to 2031.
Homeopathic Products Market: The global homeopathic products market is anticipated to reach more than US$ 32.4 Bn by the end of 2031 at a CAGR of 11.6% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/premenstrual-syndrome-treatment-market---high-demand-for-micronutrient-supplements-drive-the-industry-growth--tmr-study-301653166.html
